OpenVSafe by OpenVAERS
Search V-safe

ZND-16337-01863

3 vaccinations 6 coded responses 31 check-ins 6 free-text entries 1 call case
Sex
Female
Age at first dose
21-25
ZIP prefix
474 / IN
Registered
2021-01-07
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2020-12-21
    Dose 1 — Pfizer-BioNTech
  2. 2021-01-07
    Registered in v-safe
  3. 2021-01-07
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  4. 2021-01-11
    Health check-in — day 21, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-01-12
    Dose 2 — Pfizer-BioNTech
  6. 2021-01-12
    Health check-in — day 0, dose 2
    Feeling: Good · Site: Pain · None
    Adult check-in
  7. 2021-01-13
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches
    Adult check-in
  8. 2021-01-14
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  9. 2021-01-15
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  10. 2021-01-16
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  11. 2021-01-17
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  12. 2021-01-18
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · None
    Adult check-in
  13. 2021-01-19
    Health check-in — day 7, dose 2
    Feeling: Good · None
    Adult check-in
  14. 2021-01-26
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  15. 2021-02-03
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  16. 2021-02-09
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  17. 2021-02-16
    Health check-in — day 35, dose 2
    Feeling: Good
    Adult check-in
  18. 2021-02-23
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  19. 2021-04-13
    Health check-in — 3 months, dose 2
    Feeling: Good
    Adult check-in
  20. 2021-07-13
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  21. 2021-09-26
    Dose 3 — Pfizer-BioNTech
  22. 2021-09-27
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Fever · Chills, Fatigue or tiredness
    Adult check-in
  23. 2021-09-28
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Fair · Site: Pain
    Free text: Left supraclavicular lymph node swelling and pain
    MedDRA releases: 2024-11 · check-in free text available
  24. 2021-09-29
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymph node pain, Lymphadenopathy — Feeling: Good · Site: Pain
    Free text: Left supraclavicular lymph node swelling and pain (better than yesterday)
    MedDRA releases: 2024-11 · check-in free text available
  25. 2021-10-01
    Survey response — days 1–6 daily, dose 3
    MedDRA: Lymphadenopathy — Feeling: Good
    Free text: Left supraclavicular lymph node swelling (mild)
    MedDRA releases: 2024-11 · check-in free text available
  26. 2021-10-02
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · None
    Adult check-in
  27. 2021-10-03
    Health check-in — day 7, dose 3
    Feeling: Good · None
    Adult check-in
  28. 2021-10-10
    Health check-in — day 14, dose 3
    Feeling: Good
    Adult check-in
  29. 2021-10-17
    Survey response — day 21, dose 3
    MedDRA: Anosmia, Brain fog, Decreased appetite, Fatigue, Paranasal sinus discomfort, Sinusitis, Sneezing — Feeling: Poor · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Sinus infection - sinus pressure, sneezing, brain fog, fatigue, loss of smell and appetite
    MedDRA releases: 2024-11 · check-in free text available
  30. 2021-10-26
    Health check-in — day 28, dose 3
    Feeling: Good
    Adult check-in
  31. 2021-10-31
    Health check-in — day 35, dose 3
    Feeling: Good
    Adult check-in
  32. 2021-11-07
    Health check-in — day 42, dose 3
    Feeling: Good
    Adult check-in
  33. 2021-12-26
    Survey response — 3 months, dose 3
    MedDRA: Bronchitis, SARS-CoV-2 test negative — Feeling: Fair · Be unable to do your normal daily activities
    Free text: Bronchitis - negative COVID tests x2
    MedDRA releases: 2024-11 · check-in free text available
  34. 2022-03-27
    Health check-in — 6 months, dose 3
    Feeling: Good
    Adult check-in
  35. 2022-09-26
    Survey response — 12 months, dose 3
    MedDRA: COVID-19, Conjunctivitis, Cough, Headache, Malaise, Rhinorrhoea — Feeling: Good · Be unable to work or attend school, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation
    Free text: COVID symptoms 8.26.22 - dry cough, conjunctivitis, slight runny nose, headache. Treated with Paxlovid, positive 12 days.
    MedDRA releases: 2024-11 · check-in free text available
  36. 2022-09-26
    Report sent to call center — 12 months, dose 3
    Be unable to work or attend school · Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · 1 call case(s)
  37. 2022-09-27

Vaccinations

DoseDateManufacturerCo-administered
12020-12-21Pfizer-BioNTech
22021-01-12Pfizer-BioNTech
32021-09-26Pfizer-BioNTech No

Call center

ReportedOutcomeVAERS-related outcome
2022-09-26 Unsuccessful

Free text

Release 9 — days 1–6 daily, dose 3

2021-09-28

Systemic reaction (other): Left supraclavicular lymph node swelling and pain

2021-09-29

Systemic reaction (other): Left supraclavicular lymph node swelling and pain (better than yesterday)

2021-10-01

Systemic reaction (other): Left supraclavicular lymph node swelling (mild)

Release 10 — day 21, dose 3

2021-10-17

Symptoms: Sinus infection - sinus pressure, sneezing, brain fog, fatigue, loss of smell and appetite

Release 10 — 3 months, dose 3

2021-12-26

Symptoms: Bronchitis - negative COVID tests x2

Release 12 — 12 months, dose 3

2022-09-26

Symptoms: COVID symptoms 8.26.22 - dry cough, conjunctivitis, slight runny nose, headache. Treated with Paxlovid, positive 12 days.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDAnosmia · · ✓
SDBrain fog · · ✓
SDBronchitis · · ✓
SDConjunctivitis · · ✓
SDCough · · ✓
SDCOVID-19 · · ✓
SDDecreased appetite · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDMalaise · · ✓
SDParanasal sinus discomfort · · ✓
SDRhinorrhoea · · ✓
SDSARS-CoV-2 test negative · · ✓
SDSinusitis · · ✓
SDSneezing · · ✓
SROLymph node pain · · ✓
SROLymphadenopathy · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release